UROGEN PHARMA LTD

$URGN
Smart money positioned

12 of the Top-200 alpha managers hold $URGN as of the latest 13F snapshot.

13F holders
157
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

12 holders · Q1 2026

$URGN is held by 12 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.89%, with an average of 0.20% of portfolio. Largest holder: Lpwm LLC at 0.89%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 157 · Source: 13F-HR
01
Glynn Capital Management LLC
0.07% of portfolio
2,616,714 sh
02
Kynam Capital Management, LP
2.49% of portfolio
2,247,393 sh
03
Fairfax Financial Holdings LTD/ Can
0.27% of portfolio
2,199,652 sh
04
Jefferies Financial Group Inc.
0.26% of portfolio
2,199,652 sh
05
Wealth Dimensions Group, Ltd.
0.63% of portfolio
1,703,949 sh
06
Mink Brook Asset Management LLC
8.55% of portfolio
1,673,420 sh
07
Insight Holdings Group, LLC
0.03% of portfolio
1,657,846 sh
08
Massachusetts Institute of Technology
0.02% of portfolio
1,637,570 sh
09
Awm Capital, LLC
3.18% of portfolio
1,503,045 sh
10
Municipal Employees' Retirement System of Michigan
3.39% of portfolio
1,430,000 sh
See all 157 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $URGN in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $URGN in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 09:16 UTC.